These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23514202)

  • 1. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
    Curriu M; Carrillo J; Massanella M; Rigau J; Alegre J; Puig J; Garcia-Quintana AM; Castro-Marrero J; Negredo E; Clotet B; Cabrera C; Blanco J
    J Transl Med; 2013 Mar; 11():68. PubMed ID: 23514202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Rivas JL; Palencia T; Fernández G; García M
    Front Immunol; 2018; 9():1028. PubMed ID: 29867995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological abnormalities in patients with chronic fatigue syndrome.
    Tirelli U; Marotta G; Improta S; Pinto A
    Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
    J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic abnormalities in chronic fatigue syndrome.
    Klimas NG; Salvato FR; Morgan R; Fletcher MA
    J Clin Microbiol; 1990 Jun; 28(6):1403-10. PubMed ID: 2166084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Hardcastle SL; Keane J; Tajouri L; Peterson D; Ramos SB; Marshall-Gradisnik SM
    J Transl Med; 2012 May; 10():88. PubMed ID: 22571715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic abnormalities associated with chronic fatigue syndrome.
    Barker E; Fujimura SF; Fadem MB; Landay AL; Levy JA
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S136-41. PubMed ID: 8148441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic fatigue immune dysfunction syndrome].
    Uchida A
    Nihon Rinsho; 1992 Nov; 50(11):2625-9. PubMed ID: 1287238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
    BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
    Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome.
    Hanevik K; Kristoffersen EK; Sørnes S; Mørch K; Næss H; Rivenes AC; Bødtker JE; Hausken T; Langeland N
    BMC Infect Dis; 2012 Oct; 12():258. PubMed ID: 23061432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies.
    Boldt A; Borte S; Fricke S; Kentouche K; Emmrich F; Borte M; Kahlenberg F; Sack U
    Cytometry B Clin Cytom; 2014 May; 86(3):191-206. PubMed ID: 24488780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M; Bosmans E; Kubera M
    Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
    Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
    PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.
    Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG
    PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
    J Transl Med; 2015 Sep; 13():299. PubMed ID: 26370228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.